Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Kolesnick

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
The Journal of Clinical Investigation|July 3, 2002
The therapeutic potential of modulating the ceramide/sphingomyelin pathwayRichard Kolesnick
FEBS Letters|February 25, 2010
Ceramide-rich platforms in transmembrane signalingBranka Stancevic, Richard Kolesnick
Cell Metabolism|December 3, 2014
C16:0-ceramide signals insulin resistanceTimothy Hla, Richard Kolesnick
Sub-Cellular Biochemistry|June 1, 2002
Acid sphingomyelinase-derived ceramide signaling in apoptosisErich Gulbins, Richard Kolesnick
Cancer Cell|August 16, 2005
Engaging the vascular component of the tumor responseZvi Fuks, Richard Kolesnick
Handbook of Experimental Pharmacology|April 9, 2013
Using ASMase knockout mice to model human diseasesGuoqiang Hua, Richard Kolesnick
Biological Chemistry|February 27, 2015
Caenorhabditis elegans as a model to study sphingolipid signalingXinzhu Deng, Richard Kolesnick
Pharmacological Research|April 5, 2003
Sphingolipids as therapeuticsMark Kester, Richard Kolesnick
Oncogene|August 30, 2003
Radiation and ceramide-induced apoptosisRichard Kolesnick, Zvi Fuks
Oncogene|October 15, 2003
Raft ceramide in molecular medicineErich Gulbins, Richard Kolesnick
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
The Journal of Clinical Investigation|July 3, 2002
The therapeutic potential of modulating the ceramide/sphingomyelin pathwayRichard Kolesnick
FEBS Letters|February 25, 2010
Ceramide-rich platforms in transmembrane signalingBranka Stancevic, Richard Kolesnick
Cell Metabolism|December 3, 2014
C16:0-ceramide signals insulin resistanceTimothy Hla, Richard Kolesnick
Sub-Cellular Biochemistry|June 1, 2002
Acid sphingomyelinase-derived ceramide signaling in apoptosisErich Gulbins, Richard Kolesnick
Cancer Cell|August 16, 2005
Engaging the vascular component of the tumor responseZvi Fuks, Richard Kolesnick
Handbook of Experimental Pharmacology|April 9, 2013
Using ASMase knockout mice to model human diseasesGuoqiang Hua, Richard Kolesnick
Biological Chemistry|February 27, 2015
Caenorhabditis elegans as a model to study sphingolipid signalingXinzhu Deng, Richard Kolesnick
Pharmacological Research|April 5, 2003
Sphingolipids as therapeuticsMark Kester, Richard Kolesnick
Oncogene|August 30, 2003
Radiation and ceramide-induced apoptosisRichard Kolesnick, Zvi Fuks
Oncogene|October 15, 2003
Raft ceramide in molecular medicineErich Gulbins, Richard Kolesnick
Pageof 10